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GABA and its type A receptor (GABAAR) are present in the immature CNS and may function as growth-regulatory signals during the
development of embryonic neural precursor cells. In the present study, on the basis of their isopycnic properties in a buoyant density
gradient, we developed an isolation procedure that allowed us to purify proliferative neural precursor cells from early postnatal rat
striatum, which expressed the polysialylated form of the neural cell adhesion molecule (PSA-NCAM). These postnatal striatal PSA-
NCAM cells were shown to proliferate in the presence of epidermal growth factor (EGF) and formed spheres that preferentially
generated neurons in vitro. We demonstrated that PSA-NCAM neuronal precursors from postnatal striatum expressed GABAAR
subunits in vitro and in situ. GABA elicited chloride currents in PSA-NCAM cells by activation of functional GABAAR that displayed a
typical pharmacological profile. GABAAR activation in PSA-NCAM
 cells triggered a complex intracellular signaling combining a tonic
inhibition of the mitogen-activated protein kinase cascade and an increase of intracellular calcium concentration by opening of voltage-
gated calcium channels. We observed that the activation of GABAAR in PSA-NCAM
 neuronal precursors from postnatal striatum
inhibited cell cycle progression both in neurospheres and in organotypic slices. Furthermore, postnatal PSA-NCAM striatal cells
synthesized and released GABA, thus creating an autocrine/paracrine mechanism that controls their proliferation. We showed that EGF
modulated this autocrine/paracrine loop by decreasing GABA production in PSA-NCAM cells. This demonstration of GABA synthesis
and GABAAR function in striatal PSA-NCAM
 cells may shed new light on the understanding of key extrinsic cues that regulate the
developmental potential of postnatal neuronal precursors in the CNS.
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Introduction
During CNS development, all types of neurons and glial cells are
derived from primordial neural stem cells (NSCs) (Edlund and
Jessell, 1999) and emerge, according to a precise time schedule,
through a complex sequence of intermediate precursors. Al-
though the conventional view of the adult CNS used to be a
structurally constant organ, recent experimental evidence deter-
mined that cells are regularly added de novo to several CNS areas
during adulthood (for review, see Gross, 2000). NSCs are defined
by their ability to self-renew and to generate the main cell lineages
of the CNS (McKay, 1997). NSCs have been isolated from em-
bryonic and newborn CNS as well as from specific restricted re-
gions of the adult mammalian CNS, including the subventricular
zone [(SVZ) postnatally termed the subependymal zone] and the
dentate gyrus of the hippocampus (for review, see Weissman et
al., 2001). At early stages of CNS cell fate determination, NSCs
give rise to progenitors that express the polysialylated form of the
neural cell adhesion molecule (PSA-NCAM) (Doetsch et al.,
1999). Many tissues expressing PSA-NCAM during development
show a progressive loss of PSA carbohydrate residues, but PSA-
NCAM cells persist in several adult brain regions in which neu-
ronal plasticity and sustained formation of new neurons occur
(Bonfanti et al., 1992; Seki and Arai, 1993; Doetsch et al., 1997).
PSA-NCAM has been shown to be involved in changes of cell
morphology that are necessary for motility, axonal guidance, syn-
apse formation, and functional plasticity in the CNS (for review,
see Yoshida et al., 1999; Bruses and Rutishauser, 2001).
Although they are already restricted to either a glial (Trotter et
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al., 1989; Grinspan and Franceschini, 1995; Ben Hur et al., 1998;
Vitry et al., 1999) or a neuronal (Mayer-Proschel et al., 1997)
preferential fate, cultured PSA-NCAM progenitors preserve a
relative degree of pluripotentiality (Marmur et al., 1998; Vitry et
al., 2001). Considering that PSA-NCAM cells can be neatly used
for brain repair purposes (Keirstead et al., 1999; Vitry et al.,
2001), there is much interest in studying signaling factors that
regulate their development. In this regard, it has been known for
many years that neurotransmitters, which belong to the micro-
environment of neural cells in vivo, regulate morphogenetic
events preceding synaptogenesis such as cell proliferation, migra-
tion, differentiation, and death (for review, see Nguyen et al.,
2001). Along this line, previous reports have suggested that
GABA, the major inhibitory neurotransmitter in the mammalian
brain, exerts trophic roles during CNS embryonic and postnatal
development (Barker et al., 1998).
To investigate whether GABA may control the proliferation of
postnatal PSA-NCAMneural precursors, we first established an
isolation procedure that allows the purification of PSA-NCAM
precursors from newborn rat striata. Using this in vitro prepara-
tion together with postnatal striatal organotypic slices, we report
the following: (1) epidermal growth factor (EGF)-responsive
proliferative PSA-NCAM precursors generate spheres commit-
ted mostly to a neuronal fate; (2) postnatal PSA-NCAMprecur-
sors express functional type A GABA receptors (GABAARs) and
glutamate decarboxylase (GAD) 65 and GAD 67; (3) prolifera-
tion of PSA-NCAM precursors is inhibited by an EGF-
controlled endogenous production of GABA that activates
GABAAR in these cells; and (4) GABAAR-dependent inhibition of
PSA-NCAM cell proliferation is mediated by a complex intra-
cellular signaling involving notably the inhibition of the mitogen-
activated protein kinase (MAPK) pathway and an increase of
intracellular calcium concentration by opening of voltage-gated
calcium channels.
Materials and Methods
Sequential purification of PSA-NCAM progenitors. Newborn Wistar rats
(0- to 3-d-old rat pups) were raised from our animal facility. They were
killed following National Institutes of Health animal welfare guidelines.
Briefly, rats were anesthetized and subsequently decapitated. Striata were
dissected out and collected in PBS solution supplemented with glucose at
4.5 gm/l. Next, isolated striata, possibly including small parts of subven-
tricular zones, were gently triturated in PBS-HEPES (25 mM) by passing
through a fire-polished Pasteur pipette before being filtered with a 15m
nylon mesh. The cell suspension was then layered on top of a pre-
centrifuged (15 min at 26,000 g) Percoll density gradient (1.04 gm/ml;
Amersham Biosciences, Uppsala, Sweden) and further ultracentrifuged
for 15 min at 26,000 g. Proliferating PSA-NCAMprecursor cells were
separated from differentiated postmitotic neural cells and cell debris by
collecting the interphase located between the bands at 1.052 and 1.102
gm/ml as determined by using density marker beads (Amersham Bio-
sciences) for the calibration of the Percoll gradient after centrifugation
(Maric et al., 1997) (see Fig. 1 A, B). The resulting suspension was then
centrifuged three times (10 min at 400  g) in PBS-HEPES to eliminate
Percoll. The final pellet was resuspended in DMEM/F12 (1:1, v/v; In-
vitrogen, Merelbeke, Belgium) medium supplemented with 1% (v/v) N2
(25g/ml bovine insulin, 100g/ml transferrin, 20 nM progesterone, 60
M putrescine, 30 nM sodium selenite), 1% (v/v) B27 (Invitrogen) with
or without EGF (20 ng/ml) supplementation (PeproTech, Rocky Hill,
NJ). We refer hereafter to these media as either EGF-containing or EGF-
free medium. The final cell suspension was plated either in 50l droplets
on poly-ornithine-coated (Becton Dickinson, Erembodegem, Belgium)
coverslips at a density of 2.10 6 cells/ml for immunocytochemical studies
or onto uncoated nonadherent T25 culture flasks in 5 ml of EGF-
containing medium at a density of 2.10 5 cells/ml (Sarstedt, Newton,
NC). Cells grown in uncoated conditions generated floating spheres (see
Fig. 1 I). After 3 d in EGF-containing medium, growing spheres were
allowed to attach for 1 hr on poly-ornithine-coated coverslips before
being used further for patch-clamp recordings or immunocytochemical
studies.
Immunostainings. Cultures were fixed with 4% (v/v) paraformalde-
hyde for 10 min at room temperature and permeabilized in 0.1% Triton
X-100 (v/v) for 15 min during which subsequent immunostainings were
directed toward cytoplasmic epitopes. For anti-GABAA  subunit stain-
ing, cells were fixed with a methanol/acetic acid (95:5, v/v) mixture for 5
min. For all immunostainings, nonspecific binding was blocked by a 30
min treatment in a PBS solution containing nonfat dry milk (15 mg/ml).
Cells were then incubated overnight at 4°C with primary antibodies, i.e.,
mouse anti-PSA-NCAM at 1:500 (anti-Men-B antibody; generous gift
from G. Rougon, Universite´ de la Me´diterrane´e, Marseille, France), rab-
bit anti-nestin at 1:400 (generous gift from Prof. J. Eriksson, University of
Turku, Turku, Finland), mouse anti-A2B5 at 1:100 (Boehringer Mann-
heim, Mannheim. Germany), mouse anti-III tubulin at 1:1500 (clone
Tuj1, Babco, Richmond, CA), mouse anti-MAP2ab at 1:100 (clone AP20,
Boehringer Mannheim), mouse monoclonal anti-O4 at 1:150 (Chemi-
con, Temecula, CA), rabbit anti-glial fibrillary acidic protein (GFAP) at
1:1500 (Dako, Prosan, Belgium), rabbit anti-NF-M at 1:350 (Chemicon),
mouse anti-synaptophysin at 1:200 (Sigma-Aldrich, Bornem, Belgium),
goat anti-GABAA  subunits (1–3, 5) at 1:40 (clone C-20, Santa Cruz
Biotechnology, Santa Cruz, CA), goat anti-GABAA 1–3 subunits at 1:50
(clone N-19, Santa Cruz Biotechnology), goat anti-GABAA1– 4 subunits
antibody at 1:50 (clone M-20, Santa Cruz Biotechnology), rabbit anti-
GABA at 1:400 (Incstar, Stillwater, MN), rabbit anti-GAD (GAD 67) at
1:500 (Biogenesis, Poole, UK), and rabbit anti-GAD 65 at 1:50 (clone
H-95, Santa Cruz Biotechnology). Secondary antibodies were diluted in
PBS solution and applied for 45 min at room temperature. These in-
cluded Cy5-, FITC-, or TRITC-conjugated anti-rabbit Ig antibodies (1:
500), Cy5-, FITC-, or TRITC-conjugated anti-mouse IgG (1:500), and
Cy5-, FITC-, or TRITC-conjugated anti-mouse IgM (all from Jackson
ImmunoResearch Laboratory, West Grove, PA), or FITC- or TRITC-
conjugated anti-mouse IgG2a (ImTec Diagnostics, Antwerp, Belgium).
Three rinses in PBS were performed between different steps. Prepara-
tions were mounted in Fluoprep (Biomerieux). Images were acquired
using a laser scanning confocal microscope (MRC1024, Bio-Rad, Hert-
fordshire, UK).
For quantitative immunostainings, before immunocytochemical pro-
cedure, spheres were mechanically dissociated and further plated onto
poly-ornithine-coated coverslips. Cells were allowed to attach for 1 hr
before fixation. For counting, cells were counterstained with the nuclear
dye ethidium homodimer-1 (Etd1) (applied at 6.10 7 M for 7 min; Mo-
lecular Probes, Leiden, The Netherlands) or Hoescht 33258 (0.4 g/ml
for 15 min). Ten nonoverlapping microscopic fields (50 cells per field)
(Axiovert 135 fluorescence microscope, 40 objective; Zeiss) were
counted for each coverslip in a minimum of two or three separate
experiments.
Frozen 30 m tissue sections were prepared as described previously
(Yuan et al., 2002). Immunohistochemical stainings were processed fol-
lowing a procedure identical to that of cultured cells.
Electrophysiological recordings. For patch-clamp recordings, Cell-Tak
(Becton Dickinson)-coated coverslips containing 1–3 hr adhesive
spheres were transferred to the stage of a Zeiss interferential contrast
microscope equipped with fluorescence. Coverslips were maintained at
37°C in a recording chamber that was perfused continuously with a saline
solution containing (in mM): 116.0 NaCl, 11.1 D-glucose, 5.4 KCl, 5.4, 1.8
CaCl22H2O, 2.0 MgCl26H2O, 10.0 HEPES, pH 7.2. Cs
-containing
solutions were composed as follows (in mM): 116.0 NaCl, 5.4 CsCl, 11.1
D-glucose, 1.8 CaCl22H2O, 2.0 MgCl26H2O, 9.0 HCl, 5.0 HEPES, 26.2
NaHCO3, 5.0 BaCl22H2O, pH 7.2. Low chloride solution contained (in
mM): 8.0 NaCl, 108.0 Na-gluconate, 5.4 CsCl, 5.4, 11.1 D-glucose,
1.8 CaCl22H2O, 2.0 MgCl26H2O, 17.0 HCl, 5.0 HEPES, 26.2 NaHCO3,
5.0 BaCl22H2O, pH 7.4. All drugs were applied by a microperfusion
system (SPS-8, List Medical). Borosilicate recording electrodes (15–20
M) were made using a Flaming-Brown microelectrode puller (P97,
Sutter Instruments Novato, CA). Micropipettes were filled with an
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intracellular-like solution containing (in mM): 130.0 KCl, 1.0
CaCl22H2O, 11.1 D-glucose, 10.0 EGTA, 2.5 Na2-ATP, 2.5 Mg-ATP, 10.0
HEPES, pH 7.4. In Cs-containing pipettes, used for the establishment
of the GABA-evoked current–voltage relationship, KCl was equimolarly
replaced by CsCl and BaCl22H2O was added at 5 mM to block K
 chan-
nels. Current–voltage relationships were obtained using a series of volt-
age steps (ranging from 140 to 100 mV) before, during, and after
application of GABA. The current–voltage curve was established by fit-
ting experimental data to the Goldman-Hodgkin and Katz equation:




S i  So  expZS  F  ER  T
1 expZS  F  ER  T
,
where Is corresponds to the current generated (ampere), Ps the mem-
brane permeability, Zs the valence, [S]i the intracellular concentration
(Ml 1), and [S]o the extracellular concentration (Ml
 1) of the ion S,
respectively. E corresponds to the membrane potential, F is the Faraday’s
constant, R is the ideal gas constant, and T is the absolute temperature.
Electrophysiological recordings were performed with a patch-clamp am-
plifier (RK400, Bio-Logic, Claix, France) using the whole-cell configura-
tion of the patch-clamp recording technique (Hamill et al., 1981). Cells
were injected with Lucifer yellow (Molecular Probes) (1 g/ml Lucifer
yellow solution in the recording pipette) during voltage-clamp record-
ings to allow their post hoc immunocytochemical characterization. Series
resistances (10 –20 ) were electronically compensated (80 – 85%), and
current traces were filtered at 3 kHz, acquired and digitized at 0.5 kHz,
and stored on an personal computer system. Control of drug application,
data acquisition, and data analysis was achieved using an ITC-16 acqui-
sition board (Instrutech Corporation, Great Neck, NY) and the TIDA for
Windows software (HEKA Elektronik Lombrecht/Pfolz, Germany).
RT-PCR. Total RNAs from adult Wistar rat brains and from PSA-
NCAM spheres derived from postnatal day 0 (P0)–P3 Wistar rat striata
were extracted and purified using the RNAgents Total RNA Isolation
System kit (Promega, Leiden, The Netherlands). One microgram of total
RNA was reverse transcribed using primers with oligo-dT and 200 U of
reverse transcriptase (Kit Superscript 1, Life Technologies). Two micro-
liters resulting from the RT reaction were used as template and added to
50 l of PCR reaction mixture containing 0.2 M of both forward and
reverse primers synthesized by Eurogentec (Seraing, Belgium) (see Table
1), 0.2 mM of each dNTP, 1.5 mM of MgCl2, and 5 U of Taq Polymerase
(Promega). The PCR program was run with an MJ Research PTC 200
instrument. The thermal cycling protocol started with a 2 min preincu-
bation at 94°C followed by 35 cycles made (1) 30 sec at 94°C, (2) 30 sec at
60°C, and (3) 30 sec at 72°C. The protocol was finally completed by an
extension step at 72°C for 7 min. We used 64°C for the annealing of 3
primers and 55°C for 3, GAD 65, and GAD 67 primers. Ten microliters
of the PCR reaction were analyzed in a 1.4% agarose gel in Tris–acetic
acid–EDTA (TAE) buffer.
Bromodeoxyuridine and [3H]thymidine incorporation assays. After 2 d
of growth in EGF-containing medium (as described previously), PSA-
NCAM spheres were harvested, centrifuged (10 min at 200  g), and
rinsed three times in the EGF-free medium before being transferred into
uncoated nonadherent T25 culture flasks (Sarstedt) in mitogen-free me-
dium. After 24 hr in this medium, bromodeoxyuridine (BrdU) (20 M;
Sigma), which is a S-phase marker, was added to the cultures for 18 hr
before fixation and staining. All treatments were performed simulta-
neously with the addition of BrdU. PSA-NCAM, III tubulin, O4, and
GFAP immunolabelings were performed as described above. Coverslips
were then postfixed for 10 min in 4% (v/v) paraformaldehyde, perme-
abilized in 0.1% Triton X-100 for 10 min, incubated in 0.07N NaOH for
10 min, and finally postfixed again for 10 min before incubation with an
anti-BrdU FITC-conjugated antibody for 45 min (1:3, v/v; Becton-
Dickinson). The preparations were mounted in Fluoprep and imaged
using a Bio-Rad MRC1024 laser scanning confocal microscope. The frac-
tion of cells that incorporated BrdU was determined by counting 10
nonoverlapping microscopic fields (50 cells per field) (Axiovert 135
fluorescence microscope, 40 objective, Zeiss) for each coverslip in at
least three separate experiments.
In similar culture conditions, the proliferation of PSA-NCAM
spheres was also quantified by measuring the incorporation of [ 3H]thy-
midine (Amersham Biosciences, Roosendaal, The Netherlands). All
treatments were performed simultaneously with the addition of
[ 3H]thymidine (2 Ci/ml) to the medium for 18 hr. Cultures were
washed three time with PBS and digested with NaOH (0.1N), and the
radioactivity was counted in a liquid scintillation counter (Wallac Win-
Spectral 1414 liquid scintillation counter, Turku, Finland). The [ 3H]thy-
midine incorporation was normalized for cellular protein concentration
measured by the Bradford technique (Bradford, 1976) and expressed as
disintegrations per minute of [ 3H]thymidine incorporated per milli-
gram of protein. Results from the treated conditions were then expressed
as percentages of control values. We always performed three separate
experiments in triplicate wells for each condition.
Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling
assay. To assess apoptosis occurring in our cultures, spheres were gently
dissociated after treatments, and cells were plated for 15–30 min on
Cell-Tak (Becton Dickinson)-coated coverslips at a density of 2.10 6 cells/
ml. Terminal deoxynucleotidyl transferase-mediated dUTP nick end la-
beling (TUNEL) staining was then performed according to the method of
Gavrieli et al.(1992), using the ApopTag fluorescent detection kit (On-
cor, Gaithersburg, MD). Cultures were fixed with 4% paraformaldehyde
for 10 min at room temperature. Equilibration buffer was then applied
for 30 min at 20°C. Cultures were incubated with working strength stop/
wash buffer, washed, and further incubated with anti-digoxigenin–FITC.
For cell counting, cultures were counterstained with ethidium
homodimer-1 (Molecular Probes; applied at 6.10 7 M for 7 min). Ten
nonoverlapping microscopic fields (50 cells per field) (Axiovert 135
fluorescence microscope, 40 objective, Zeiss) were counted for each
coverslip in a minimum of three separate experiments.
HPLC procedure. We used an adaptation of a procedure described
previously (Bettendorff et al., 1996). Cultures of PSA-NCAM spheres
(25 mg) were homogenized in 1 ml of an 80% ethanol solution at 0°C in
a glass– glass homogenizer (Potter-Elvehjem device). Homogenates were
centrifuged (30 min at 5000 g), and the supernatants were saved. The
pellets were resuspended in 1 ml of a 60% ethanol solution, homoge-
nized, and centrifuged as described above. The second supernatant was
pooled with the first, and the liquids were evaporated under a stream of
nitrogen. The residue was dissolved in 300 l of water and centrifuged
(30 min, 5000 g). An aliquot of 100l from the supernatant was added
to 100l of LiCO3 (80 mM, pH 8.5) before dansylation by addition of 100
l dansyl chloride (1.5 mg/ml in acetonitrile). The mixture was incu-
bated in the dark for 35 min at 25°C, and the reaction was stopped with 10
l of 2% ethylamine.
We used a Bio-SiL C18 HL column (5 m, 150  4.6 mm; Bio-Rad
Laboratories, Nazareth-Eke, Belgium) heated at 50°C. After injection of
the dansylated solution (20 l), GABA was eluted by means of a linear
gradient at a flow rate of 1.5 ml/min. The column was equilibrated in
85% solvent A (3% tetrahydrofuran, 0.57% acetic acid, 0.088% triethyl-
amine in water) and 15% solvent B (3% tetrahydrofuran, 0.57% acetic
acid, 0.088% triethylamine, 70% methanol in water). After injection, the
percentage of solvent B was increased linearly to reach 100% after 40 min.
Initial conditions were restored within 2 min, and the next sample was
injected after a reequilibration period of 5 min. A fluorescent spectrom-
eter (LS-4, Perkin-Elmer, Norwalk, CT) was used with the wavelengths
set at 334 nm for excitation and 522 nm for emission. A reference stan-
dard, composed of a GABA solution (0.1 mM) in water, was dansylated
simultaneously with samples.
Calcium imaging. PSA-NCAM cells were loaded with the calcium
indicator dye fluo-3 AM (6 M) (Molecular Probes) by bath application
for 30 min at 37°C. Fluo-3 AM is a non-ratiometric indicator dye that
triggers an increase of cell fluorescence intensity when the intracellular
calcium concentration increases. After fluo-3 loading, cells were washed
three times in Locke solution containing (in mM): 154 NaCl, 5.6 KCl, 5.6
glucose 5.6, 2.3 CaCl22H2O, 10.0 HEPES, pH 7.2. Calcium responses
were recorded as digitized images acquired with a Bio-Rad MRC 1000
laser scanning confocal system coupled to a Zeiss Axiovert 135 micro-
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scope with a plan-NEOFLUAR objective (40, 1.3 numerical aperture,
oil immersion). The Time Course Software Module program (Bio-Rad)
was used to control the confocal microscope to acquire a series of images
at intervals from 2 to 5 sec. The different reagents diluted in Locke solu-
tion were applied by a microperfusion system (SPS-8, List-Medical). The
series of digitized fluorescence images were analyzed by a program that
determined the average level of fluorescence above the background level
of each cell for every time point sampled. The recorded areas were delim-
ited by placing rectangular boxes around every cell in a field. A “back-
ground” box was also defined in a noncellular area of each scanned
image. The averaged intensity of the pixels within a boxed cellular region
was calculated by the program, and the averaged intensity of the pixels
within the “background” box defined for the image was subtracted from
this value. To compensate for variable dye loading between cells, these
background-corrected values were normalized by conversion to percent-
age changes relative to a baseline measurement for each boxed cellular
region at the start of a time series (Ft/F0).
Organotypic slice cultures. We used a technique adapted from Yuan et
al. (1998). Briefly, whole brains were dissected from P1 Sprague Dawley
rats and placed in oxygenated (carbogen, 95% O2/5% CO2) artificial CSF
containing (in mM): 120 NaCl, 25 NaHCO3, 3.3 KCl, 1.2 NaH2PO4, 1.8
CaCl2, 2.4 MgSO4, 10 glucose, pH 7.2. Brains were then sliced coronally
(400 m) using a vibratome. The SVZ and striatum (as depicted in Fig.
10 A1) were separately microdissected to allow a distinct assessment of
SVZ and striatal cells. SVZ and striatal slices were placed into sterile
Millicell (Millipore, Bedford, MA) in six-well plates (Falcon) containing
1 ml of EGF-free medium (as described previously). Treatments with
drugs began 4 hr after the slicing procedure. The medium was replaced by
EGF-free medium containing simultaneously BrdU (20 M; Sigma) and
drugs for 18 hr. Cell viability was assessed in each experiment at the end
of the BrdU incorporation time frame by using a LIVE/DEAD viability/
cytotoxicity kit (L-3224, Molecular Probes). Slices were then gently me-
chanically dissociated, and cells were plated for 1 hr on poly-ornithine-
coated coverslips before fixation and immunocytochemical analysis.
Drugs. GABA, muscimol, bicuculline, picrotoxin, pentobarbital, ba-
clofen, saclofen, SR-95531, U0126, and nifedipine were obtained from
Sigma-Aldrich, and clonazepam was purchased from Roche Diagnostics
Belgium (Brussels, Belgium).
Data analysis. For electrophysiological recordings, n represented the
number of recorded cells. Peak currents in the different experimental
conditions were measured and subsequently normalized to the initial
response (100%) in control conditions. Agonist concentration–response
profiles were fitted to the following equation: I/Imax 1/(1(EC50/[ago-
nist])nh), where I and Imax, respectively, represent the normalized
agonist-induced current at a given concentration and the maximum cur-
rent induced by a saturating concentration of the agonist. EC50 is the
half-maximal effective agonist concentration, and nh is the Hill slope.
The concentration–response of modulations was fitted by a similar pro-
cedure, except for clonazepam, where a polynomial curve was used.
The quantitative results of [ 3H]thymidine incorporation assays and
immunocytochemical experiments were expressed as mean  SEM val-
ues arising from a minimum of three independent experiments (n).
For all experiments, a statistical analysis was performed either using
unpaired two-tailed Student’s t test between control and experimental
conditions or using a one-way ANOVA (ANOVA-1) followed by a Dun-
nett’s post-test for multiple comparisons (GraphPad Prism software,
version 2.04 a, San Diego, CA). The level of significance was expressed as
follows: *p 	 0.05, **p 	 0.01, and ***p 	 0.0001.
Results
Purification and characterization of PSA-NCAM
progenitors acutely isolated from newborn rat striata
To obtain a highly enriched population of PSA-NCAM progen-
itors, newborn rat (P0 –P3) striata were first dissociated as de-
scribed previously for neural stem cell cultures (Reynolds and
Weiss, 1992). The cell suspension was then layered on top of a
buoyant density Percoll gradient and further ultracentrifuged
(Fig. 1A). This isopycnic centrifugation allowed cells to sediment
in an equilibrium position equivalent to their own natural buoy-
ant density. We demonstrated that viable, small (7  1 m in
diameter), round cells were separated from more differentiated
cells and cell debris by collecting the interphase located in the
range of densities between 1.052 and 1.102 gm/ml (Fig. 1B). The
final cell suspension harvested according to these density criteria
was resuspended in EGF-containing medium.
To validate our protocol of purification, we assessed PSA-
NCAM cells before and after the Percoll centrifugation. The
isopycnic centrifugation of cell suspension in a buoyant density
gradient allowed us to increase the percentage of PSA-NCAM
cells from 62.5 15.1% (n 3) to 94 1.0% of total cells (n
6) (Fig. 1C–E). After purification by the Percoll centrifugation
step, the phenotype of PSA-NCAM cell suspension was charac-
terized more extensively. Nestin was observed in 74.9  8.3%
(n  4) of total cells, and all nestin cells also expressed PSA-
NCAM (Fig. 1E). We observed that 47.6  4.5% of total cells
(n 2) were A2B5 (Fig. 1E). Neuronal phenotypes were inves-
tigated by studying the expression of neuron-specific antigens.
We found that 74.6 1.4% (n 4) of total acutely purified cells
expressedIII-tubulin (i.e., Tuj1) (Fig. 1E,F), 4.5 2.6% (n
2) expressed type 2a,b microtubule-associated protein (i.e.,
MAP2ab) (Fig. 1E,G), and 2.6 1.6% (n 2) were neurofila-
ment 145 kDa-positive (i.e., NF-M) (Fig. 1E,H). Importantly,
we never found cells that were immunoreactive for synaptophy-
sin, which is a marker of synapse formation (Fig. 1E). Finally, we
found a low expression of oligodendrocyte (O4) or astrocyte
(GFAP) specific markers. Respectively, 2.8  1.2% (n  4) of
total cells were O4 and 4.4  0.8% of total cells (n  4) were
GFAP (Fig. 1E). These results provide evidence that purified
PSA-NCAM cells from early postnatal rat striatum mostly show
antigenic features of neuron-committed progenitor cells.
Purified proliferative PSA-NCAM cells form spheres that
preferentially generate neurons
After 3 d in vitro (DIV) in EGF-containing medium, PSA-
NCAM progenitor cells proliferated and formed spheres with a
mean diameter of 61.8 7.3M (n 4) (Fig. 1 I). A vast majority
of cells within 3-DIV-old spheres remained PSA-NCAM
(89.6  4.7% of total cells; n  6), and Tuj1 (57.3  1.2% of
total cells; n 4) (Fig. 1 J,M). Interestingly, we observed that all
Tuj1 cells were still PSA-NCAM in 3-DIV spheres (data not
shown). To quantify cell proliferation within PSA-NCAM
spheres, we performed a BrdU incorporation assay (18 hr) at 3
DIV. The BrdU incorporation index (BrdU cells per total cells)
was 17.2 4.0% in the presence of EGF (20 ng/ml) (n 2) (Fig.
1K,L). By double immunostaining, we observed that proliferat-
ing cells were mostly PSA-NCAM because 16.0 4.1% of total
cells (n  3) were immunoreactive for both PSA-NCAM and
BrdU (Fig. 1K,L, left panel). The other way around, we showed
that 92.9  4.1% of the total BrdU cells were PSA-NCAM
(Fig. 1L, right panel). Conversely, cells expressing markers of
lineage commitment were weakly involved in the overall BrdU
incorporation index because only 3% of Tuj1 cells, 1% of O4
cells, and 2% of GFAP cells were also BrdU (Fig. 1L, left
panel). Interestingly, cultured PSA-NCAM cells generated pre-
dominantly neuron-committed cells after 3 DIV in EGF-
containing medium (Fig. 1E,M–O). As compared with acutely
purified cells, we observed a fourfold and a fivefold increase,
respectively, of the relative percentages of MAP2ab and
NF-M cells in 3-DIV spheres, whereas no change was observed
for O4 or GFAP cells. Furthermore, with respect to the calcu-
lated 1.8-fold increase of the total cell number during the 3-DIV
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growth of PSA-NCAM spheres (data not
shown), the absolute number of cells ex-
pressing mature neuronal antigens
MAP2ab and NF-M were increased by
seven- and eightfold, respectively (Figs.
1N,O).
PSA-NCAM spheres express type A
GABA receptors
Given that previous works reported the ex-
pression of GABAAR in early postnatal
neuronal progenitor cells, notably in the
anterior subventricular zone, we sought to
investigate the presence of these receptors
in striatal PSA-NCAM neuronal precur-
sors (Stewart et al., 2002). To characterize
GABAAR subunit transcripts expressed in
PSA-NCAM progenitors, total RNAs ex-
tracted from 3-DIV spheres were reverse
transcribed, and the subsequent cDNAs
were amplified by PCR using specific sets
of primers aimed at detecting transcripts
for1–5,1–3, 1–3, and GABAAR subunit
genes (Table 1). Experiments were repli-
cated three times and consistently yielded
bands with the appropriate amplicon size
for 2 (549 bp), 4 (532 bp), 5 (300 bp),
1 (578 bp), 3 (587 bp), 1 (296 bp), 2
(423 bp), and 3 (336 bp) transcripts, re-
spectively (Fig. 2A,B). RNAs isolated from
total adult rat brains were used as positive
control.
The expression of GABAAR subunit
proteins was analyzed by immunocyto-
chemistry in PSA-NCAM spheres. We
used three polyclonal antibodies directed
against 1–3,5, 1–3, and 1– 4 subunits, re-
spectively, of GABAAR. As illustrated in
Figure 2C–E, 70.6  13.8% of total cells
(counted after mechanical dissociation of
spheres) were immunoreactive for
GABAAR  subunit proteins (i.e., 1–3,5;
n 2) (Fig. 2C), 65.6 4.3% of total cells
were immunoreactive for GABAAR  sub-
units (i.e., 1–3; n  2) (Fig. 2D), and
66.6  6.2% of total cells expressed
GABAAR subunits (i.e.,1– 4; n 3) (Fig.
2E).
GABA triggers whole-cell currents in
PSA-NCAM spheres by GABAA
receptor activation
We wanted to ascertain by electrophysio-
logical recordings whether PSA-NCAM
cells expressed functional GABAA recep-
tors. We therefore recorded cells within
PSA-NCAM spheres using the whole-
cell patch-clamp technique. Occasionally,
the Lucifer yellow fluorescent dye was
added to the intracellular solution and al-
lowed to diffuse in the recorded cell for
post hoc immunostainings. All recorded
cells filled with Lucifer yellow were PSA-
Figure 1. Purification and in vitro amplification of proliferative and neurogenic PSA-NCAM progenitors from early postnatal
striatum. A, Bands of color-coded density marker beads in ultracentrifuged Percoll gradient. According to their isopycnic buoyant
densities, living PSA-NCAM cells ( B) were separated from differentiated neural cells and cell debris in a continuous Percoll
gradient. Cells were collected in the interphase located between the ranges of density: 1052–1102 gm/ml as determined by a tube
containing control density beads that was ultracentrifuged simultaneously. C, D, Confocal images of acutely dissociated cell
suspension from newborn rat striatum before ( C ) and after ( D) selection by centrifugation in a Percoll density gradient. Cells were
immunostained for PSA-NCAM (green) and counterstained with the nuclear dye Etd1 (red). Cells acutely purified from early
postnatal striatum (1 hr) or dissociated from 3-DIV-old spheres were allowed to adhere onto poly-ornithine-coated coverslips and
were assessed by immunostaining. E, Histogram comparing the percentage of total cells expressing various markers 1 hr after
purification (blue bars) and after 3 d of growth in vitro in EGF-containing medium (red bars). F–H, Confocal images of represen-
tative fields showing acutely purified cells immunostained for markers of neuronal commitment: F, Tuj1 (green); G, MAP2ab
(green); H, NF-M (green), and F–H, counterstaining with Etd1 (red). Purified cells cultured in EGF-containing medium for 3 d in
uncoated conditions formed spheres ( I ) that were composed almost exclusively of PSA-NCAM cells. J, PSA-NCAM in green and
Etd1 in red. K, Confocal optical section of a 3-DIV sphere immunostained for BrdU after 18 hr of BrdU incorporation assay in
EGF-containing medium (PSA-NCAM in green and BrdU in red). L, Histograms representing the percentage of total cells that
incorporated BrdU (20 M) for each immunophenotype (left panel) and the percentage of total BrdU cells that expressed a
given immunophenotype (right panel), respectively, in the presence (black bars) or absence (open bar) of EGF (20 ng/ml). M–O,
Confocal optical section of 3-DIV spheres expressing markers of neuron commitment: M, Tuj1 (green); N, MAP2ab (green); O, NF-M
(green) and counterstaining with Etd1 (red). Scale bars: B–D, 10m; F–K, 25m; M–O, 20m.
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NCAM in 3-DIV spheres (Fig. 3A). We selectively assessed cells
that were located at the accessible periphery of the spheres. The
mean membrane potential recorded in current-clamp configura-
tion was 52.9  1.9 mV (n  110 cells). All recordings were
performed in the presence of 1 M strychnine to avoid cross-
activation of ionotropic glycine receptors. In voltage-clamp
mode (the holding potential was kept at70 mV), bath applica-
tion of 1 mM GABA, a concentration that saturates GABAARs
(Fig. 3C), elicited inward currents in 94.6% of total cells with a
peak current displaying a mean maximum amplitude of 408.9
46.8 pA (n  53 cells) (Fig. 3B).
In GABA-responsive PSA-NCAM progenitors, the EC50
value (i.e., the concentration that yielded an inward current of
half-maximum amplitude) calculated from the sigmoidal con-
centration–response curve was 6.2  1.1 M, with a Hill coeffi-
cient (nh) of 0.7 0.2 (n 11 cells) (Fig. 3C,D). To confirm that
GABA-elicited currents were caused specifically by the
activation of GABAARs, we showed that the specific GABAAR ago-
nist muscimol also induced inward currents in PSA-NCAM cells
(Fig. 3F). For muscimol-induced currents, the concentration–
response curve, fitted by the Hill equation, yielded an EC50 of 6.5
1.1 M, with a Hill coefficient (nh) of 0.5  0.2 (n  5 cells) (Fig.
3E,F).
The current–voltage relationship of GABA-evoked currents
was obtained by applying voltage steps ranging from 140 to
100 mV during GABA application. As shown in Figure 3, G and
I, the resulting current–voltage curve could be fitted by the
Goldman-Hodgkin-Katz relation (see Materials and Methods)
and reversed at 5.9 mV (n  4 cells), which is close to the
calculated Nernst chloride equilibrium potential (1.1 mV).
When 108 mM of extracellular sodium
chloride was replaced by sodium glu-
conate, the reversal potential shifted to a
more positive value (27.9 mV; n  5
cells) (Fig. 3H, J), consistent with the pre-
dicted shift of the calculated Nernst chlo-
ride equilibrium potential (29.0 mV).
Pharmacological characterization of
functional GABAARs expressed in
striata-derived PSA-NCAM
progenitors
In 3-DIV PSA-NCAM cells, GABA-
induced currents were completely and re-
versibly inhibited in a dose-dependent
manner by the competitive antagonists
bicuculline (IC50 1.54 1.12 M; n 5
cells) (Fig. 4A,B) and SR95531 (IC50 
0.15  0.01 M; n  6 cells) (Fig. 4C,D)
and by the noncompetitive antagonist pi-
crotoxin (IC50 4.5 1.1M; n 7 cells)
(Fig. 4E,F). We also assessed the effect of
benzodiazepines and barbiturates, which
are positive allosteric modulators of
GABAAR. The effects of clonazepam and
pentobarbital were studied on currents
elicited by a low concentration of GABA (1
MEC10GABA concentration induc-
ing an inward current corresponding to
10% of the maximum GABA-evoked cur-
rent) to sensitize the detection of a en-
hancing effect. Our results showed that
clonazepam potentiated GABA currents at
concentrations ranging from 10 nM to 100 M, with a maximum
effect at 1M (212% of IGABA at EC10) (Fig. 4G,H). Pentobarbital
triggered a maximal 5.6-fold increase of the amplitude of GABA-
evoked currents in a concentration-dependent manner (EC50 
2.1  0.3 M; n 11 cells) (Fig. 5 I, J).
GABAAR activation inhibits the proliferation of
PSA-NCAM progenitors
Because the activation of ionotropic GABAAR has been reported
to affect the proliferation of neural progenitors in the ventricular
and subventricular zones of the embryonic neocortex (LoTurco
et al., 1995; Haydar et al., 2000), we decided to analyze the effect
of GABA on proliferation kinetics in striatal early postnatal PSA-
NCAM progenitor cells. After 48 hr of growth in EGF-
containing medium, spheres were transferred to the same me-
dium but devoid of EGF for the next 24 hr. This procedure
allowed us to obtain a synchronization of most cells in G0 (Jones
and Kazlauskas, 2001) before starting BrdU or [ 3H]thymidine
incorporation assays (18 hr). The removal of EGF from the me-
dium did not affect the phenotype of cells within these 3-DIV
spheres (data not shown).
To compare the proliferation rates of the different cell pheno-
types present within 3-DIV spheres, cells were colabeled for BrdU
and lineage markers (i.e., PSA-NCAM, Tuj1, O4, and GFAP)
(Fig. 5C,F, I). Cytosine arabinoside (10M) was used as an inter-
nal control inhibiting proliferation in all phenotypes. Although
agonists and antagonists of GABAAR did not modify the percent-
ages of O4/BrdU and GFAP/BrdU cells (data not shown),
treatment with GABAAR agonists (GABA at 100 M and musci-





-CAT TCT GAG CAC TCT CTC GGG AAG-3

Rev 5
-GTG ATA CGC AGG AGT TTA TTG GGC-3

396 (Khrestchatisky et al., 1989)
GABAAR2 For 5
-AGG TTG GTG CTG GCT AAC ATCC-3

Rev 5
-AAC AGA GTC AGA AGC ATT GTA AGT CC-3

549 (Khrestchatisky et al., 1991)
GABAAR3 For 5
-CAA CAT AGT GGG AAC ACC TAT CC-3

Rev 5
-GGG AGC TCT GGG GTT TGG GAT TT-3

350 (Criswell et al., 1997)
GABAAR4 For 5
-CAA AAC CTC CTC CAG AAG TTC CA-3

Rev 5
-ATG TTA AAT AAT GCC CCA AAT GTG ACT-3

532 (Wisden et al., 1991)
GABAAR5 For 5
-TGA CCA AAA CCC TCC TTG TCT TCT-3

Rev 5
-ACC GCA GCC TTT CAT CTT TCC-3

300 (Khrestchatisky et al., 1989)
GABAAR1 For 5
-GTT TGG GGC TTC TCT CTC TTT TCC T-3

Rev 5
-AGT TAC TGC TCC CTC TCC TCC ATT-3

578 (Ymer et al., 1989a)
GABAAR2 For 5
-CAG GTT CTT ATC CCA GAT TGT CCC-3

Rev 5
-GGT CCA TCT TGT TGA CAT CCA GG-3

408 (Ymer et al., 1989b)
GABAAR3 For 5
-CTT TTC GGC ATC TTC TCG GC-3

Rev 5
-TCC ACG CCA GTA ACA GCC TTG-3

587 (Ymer et al., 1989b)
GABAAR1 For 5
-TAG TAA CAA TAA AGG AAA AAC CAC CAG A-3

Rev 5
-CCA GAT TGA ACA AGG CAA AAG CT-3

296 (Ymer et al., 1990)
GABAAR2 For 5
-TGG TGA CTA TGT GGT TAT TGC CGT G-3

Rev 5
-AGG TGG GTG GCA TTG TTC ATT T-3

423 (Khrestchatisky et al., 1989)
GABAAR3 For 5
-GAA ATC ATG GCG GCT CTA GTT-3

Rev 5
-CTC CAT CAG TGC GGC AAA GAC AAA-3

336 (Stewart et al., 2002)
GABAAR For 5
-GAC TAC GTG GGC TCC AAC CTG GA-3

Rev 5
-ACT GTG GAG GTG ATG CGG ATG CT-3

398 (Zhao and Joho, 1990)
GAD 65 For 5
-CCA TTA CCC CAA TGA GCT TCT-3

Rev 5
-CCC CAA GCA GCA TCC ACG T-3

698 (Dkhissi et al., 2001)
GAD 67 For 5
-AAT TGC ACC CGT GTT TGT TCT TAT G-3

Rev 5
-AGC GCA GCC CCA GCC TTC TTT A-3

252 (Stewart et al., 2002)
For, Forward; Rev, reverse.
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mol at 100 M), but not with GABABR ag-
onist (baclofen 100 M), significantly re-
duced the percentage of PSA-NCAM
cells that incorporated BrdU (Fig. 5A) at
both the Tuj1 (Fig. 5G) and Tuj1 (Fig.
5D) stages. The addition of SR-95531 (10
M) totally abolished the muscimol (100
M)-induced decrease of proliferation in
PSA-NCAM cells (Fig. 5A) at Tuj1
(Fig. 5G) and Tuj1 stages (Fig. 5D).
EGF (20 ng/ml) increased the prolifera-
tion of PSA-NCAM cells (Fig. 5B) similarly
at Tuj1 (Fig. 5H) and Tuj1 stages (Fig.
5E) (n  4; Student’s t test; **p 	 0.01,
***p 	 0.0001) but had no effect on O4
and GFAP cells (data not shown). Interest-
ingly, muscimol (100 M) inhibited EGF-
induced increase of proliferation (n4; Stu-
dent’s t test; *p 	 0.05) in PSA-NCAM
cells (Fig. 5B) at the Tuj1 stage only (Fig.
5E,H), whereas addition of SR-95531 (10
M) totally abolished the effect of muscimol
(Fig. 5B,E). This discrepancy may reflect de-
velopmental differences of GABAAR expres-
sion and/or function between potentially
more immature Tuj1/PSA-NCAM pre-
cursors and their Tuj1/PSA-NCAMneu-
roblastic progeny.
The influence of GABAAR modulators
assessed by BrdU incorporation was also
analyzed on the whole-cell population us-
ing the [ 3H]thymidine incorporation as-
say with similar results (data not shown,
but see Fig. 8).
EGF-controlled GABA-mediated autocrine/paracrine
inhibition of proliferation in cultured PSA-NCAM cells and
Tuj1 neuron-committed precursor cells from early
postnatal striatum
To investigate whether PSA-NCAM progenitors were able to
synthesize GABA, we performed RT-PCR experiments with spe-
cific primers to detect the enzymes required for GABA synthesis
by decarboxylation of glutamate,: i.e., the 65 kDa (GAD 65) and
67 kDa (GAD 67) glutamate decarboxylases (Table 1). During
brain development, alternative splicing produces three transcript
isoforms for the GAD 67 but not the GAD 65 gene (Szabo et al.,
1994). With RNAs extracted both from 3-DIV PSA-NCAM
spheres and from control adult total brain, we detected an appro-
priate 698 bp band by using a specific set of primers for GAD 65
(Fig. 6A). For GAD 67 RT-PCR, we used a set of primers aimed at
amplifying cDNAs for the three alternatively spliced isoforms.
However, we detected only a 252 bp band corresponding to the
full-length functional isoform of GAD 67 with RNAs extracted
both from PSA-NCAM spheres and control adult total brain
(Fig. 6A). We next sought for the presence of GABAergic cells
among PSA-NCAM progenitors by immunocytochemical
stainings using antibodies directed against GABA, GAD 65, and
GAD 67. We found that GAD 65 cells represented 48.9 5.2%
(n 2) (Fig. 6B) of total cells from 3-DIV PSA-NCAM spheres,
whereas 61.5  4.1% (n  3) (Fig. 6C) of the progenitors ex-
pressed GAD 67. GABA cells represented 19.3 9.8% (n 3)
(Fig. 6D) of total cells.
Given this demonstration of GABA synthesis in striatal PSA-
NCAM cells, we next investigated whether these cells were able
to actively secrete GABA, which in turn could regulate their pro-
liferation level by an autocrine or paracrine activation of
GABAAR. To test this hypothesis of an endogenous activation of
GABAAR within PSA-NCAM
 spheres, we studied the effects on
proliferation of antagonists (SR-95531 at 10 M, picrotoxin at 5
M, and bicuculline at 100 M) and positive allosteric modula-
tors (clonazepam at 1 M and pentobarbital at 10 M) of
GABAAR in the absence of exogenously added GABA in our pro-
liferation assay. In the absence of EGF, GABAAR antagonists trig-
gered an increase (n  3; ANOVA-1 followed by a Dunnett’s
post-test; *p	 0.05, **p	 0.01), whereas positive allosteric mod-
ulators induced a decrease (n 3; not significant) of proliferation
in total PSA-NCAM and Tuj1/PSA-NCAM cells (Fig.
6E,F). The lower level of increase of BrdU labeling in total PSA-
NCAM cells in comparison with the Tuj1 subpopulation in
the presence of GABAAR antagonists underlies the fact that
Tuj1/PSA-NCAM cells were less sensitive to this pharmaco-
logical effect (data not shown). Our data suggest the existence of
an endogenous GABA-dependent inhibition of proliferation in
PSA-NCAM spheres.
Furthermore, in the presence of EGF (20 ng/ml), the GABA
antagonist SR-95531 (10M) did not increase the proliferation of
total PSA-NCAM and Tuj1/PSA-NCAM cells (Fig. 6G,H).
Therefore, using the HPLC technique, we measured the GABA
contents in spheres synchronized for 24 hr and subsequently
grown for 18 hr in DMEM/F12/N2/B27 with or without EGF (20
ng/ml). We found that EGF-treated spheres contained a lower
amount of GABA when compared with untreated cultures (n 
3; Student’s t test; *p 	 0.05) (Fig. 6 I). These results emphasize
Figure 2. GABAA receptors are expressed by PSA-NCAM
 progenitors from early postnatal striatum. A, B, RT-PCR amplifica-
tion of GABAAR1–5,1–3,1–3, and subunit transcripts using RNA extracted from 3-DIV PSA-NCAM
 spheres ( A) and adult
rat brain tissue ( B). Bands corresponding to2 (549 bp),4 (532 bp),5 (300 bp),1 (578 bp),3 (587 bp),1 (296 bp), and3
(336 bp) were detected (, with RT;, without RT). Left margins indicate migration of standard DNA markers with size indicated
in base pairs. C, Z-series confocal image of 3-DIV PSA-NCAM cells immunoreactive for GABAAR subunits (green). D, E, Confocal
images of 3-DIV PSA-NCAM spheres showing GABAAR
 cells (D, green), and GABAAR 
 cells (E, green), respectively. All
cultures were counterstained with Etd1 (red). Scale bars: C–E, 10m.
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Figure 3. GABAA receptor activation triggers chloride-mediated inward currents in PSA-NCAM
progenitor cells. A, Confocal image showing a GABA-responsive cell injected with Lucifer yellow (green) and
expressing PSA-NCAM (red). B, Histogram representing the mean maximum current induced by GABA 1 mM and the percentage of responding cells in the total recorded population of 3 DIV PSA-NCAM cells,
respectively. C, Concentration–response curve obtained from GABA-responsive PSA-NCAM progenitors. E, The specific GABAAR agonist muscimol also induced concentration-dependent currents in PSA-
NCAM cells. D, F, Traces illustrating inward currents elicited by different concentrations of GABA ( D) and muscimol ( D). G–J, Reversal potential of GABA-induced currents (EGABA ). I, J, Current–voltage
relationship of GABA-evoked currents was studied by applying voltage steps ranging from140 to100 mV repetitively every 5 sec before, during, and after GABA (100M) application. Mean control currents
(before and after GABA application) were subtracted from the currents recorded at the peak of the GABA response. G–I, Using the currents obtained in I, we constructed a current–voltage curve reversing at
5.89 mV (n 4 cells), which is close to the calculated Nernst chloride equilibrium potential (1.1 mV) (left panel). H–J, When extracellular chloride concentration was lowered ( J), the reversal potential
shifted to30.63 mV (n 5 cells), which again is close to the expected chloride equilibrium potential in this condition (29.00 mV).
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that GABA production in PSA-NCAM
cells may be controlled by EGF signaling.
GABAAR activation does not interfere
with the survival of PSA-NCAM cells
We performed TUNEL bioassays to ascer-
tain that GABAAR agonists, antagonists,
and positive allosteric modulators did
not modify the percentage of BrdU-
incorporating PSA-NCAM cells by in-
terfering with apoptotic cell death. As
shown in Figure 7A, GABAAR agonist
(muscimol 100 M), antagonist (SR-
95531 10 M), or positive allosteric mod-
ulators (pentobarbital and clonazepam)
did not influence the apoptotic events in
PSA-NCAM cells. Roscovitine at a high
concentration (40 M) (Ljungman and
Paulsen, 2001) was used as positive control
(n 3; ANOVA-1 followed by a Dunnett’s
post-test; **p 	 0.01) (Fig. 7A,B).
Intracellular signaling pathways
mediating the effects of GABAAR
activation on cell cycle progression in
PSA-NCAM progenitors
Because the mitogen-activated protein ki-
nase (MAPK) signaling pathway has been
shown to be involved in the regulation of
cell cycle progression in neuronal progen-
itor cells (Li et al., 2001), we studied the
effect of a chemical inhibition of this cas-
cade on GABAAR-mediated modulation
of PSA-NCAM cell proliferation. We
used U0126, a specific inhibitor of the
mitogen-activated kinase kinases MEK1
and MEK2 (Duncia et al., 1998). U0126
(10 M) had no effect on basal prolifera-
tion or on muscimol-induced arrest of
proliferation (Fig. 8). Conversely, we
found that U0126 totally abolished the in-
crease of proliferation induced by SR-
95531 or EGF (n 5; Student’s t test; *p	
0.05, **p 	 0.01) (Fig. 8).
As described (Belachew et al., 2000), to
assess GABA-induced calcium responses,
PSA-NCAM cells have been imaged us-
ing confocal microscopy and the calcium
indicator dye fluo-3 in Locke standard ex-
tracellular solution. In such conditions, we
first tested the presence of voltage-gated
calcium channels (VGCCs) in PSA-
NCAM cells by studying the effects of
depolarization. The application of a depo-
larizing solution containing a high K
concentration (50 mM) resulted in a pro-
longed rise of intracellular calcium con-
centration ([Ca 2]i) in 28.3% of the cells
(28 of 99 cells tested) (Fig. 9A,B). A cell
was considered to be a responding cell if it
displayed a sustained increase of its fluo-
rescence intensity that was significantly (at
least 20%) above the average baseline flu-
Figure 4. Pharmacological characterization of GABAAR expressed by PSA-NCAM
 progenitors. A–F, GABA was applied at 10
M (IGABA 10M), a concentration close to its EC50. GABA-evoked currents were reversibly inhibited by bicuculline (A, B), SR-95531
(C, D), and picrotoxin (E, F ). G–J, We also tested positive allosteric modulators of GABAAR. Clonazepam potentiated GABA-induced
currents (GABA at 1M, EC10 ) in a range of concentrations between 10 nM and 100M, with a maximal effect at 1M (G, H ). I–J,
Pentobarbital also enhanced GABA-evoked currents in a concentration-dependent manner.
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orescence. A muscimol-evoked [Ca 2]i increase was observed in
20.2% of PSA-NCAM cells (20 of 99 cells tested), and all
muscimol-responsive cells exhibited intracellular calcium re-
sponses to depolarization induced by high extracellular K (Fig.
9A,B). Muscimol-induced calcium responses in PSA-NCAM
cells were consistently inhibited by the VGCC blocker nifedipine
(10 M; n 20 cells) (Fig. 9A,B). These data suggest that GABA
interferes with [Ca 2]i homeostasis in a subpopulation (20%) of
postnatal PSA-NCAM cells from striatum by inducing a suffi-
cient depolarization to open VGCCs.
We have also investigated the effect of the VGCC blocker nifed-
ipine on GABAAR-mediated regulation of
cell cycle progression in PSA-NCAM cells.
Therefore, we provided evidence that a
GABAAR-mediated increase of [Ca
2]i in
striatal PSA-NCAM cells was involved in
GABAAR-mediated inhibition of prolifera-
tion in neuron-committed Tuj1/PSA-
NCAM progenitor cells but not in Tuj1/
PSA-NCAM cells (Fig. 9C,D).
GABAAR is expressed in PSA-NCAM

cells in situ and autocrine/paracrine
GABAAR activation regulates
proliferation of postnatal striatal PSA-
NCAM cells in organotypic slices
We performed immunostaining in coro-
nal frozen tissue sections (30 m) from
postnatal (P1) rat brains. We were able to
demonstrate that PSA-NCAM cells from
striatum as well as from the adjacent SVZ
were immunoreactive for GABAAR  sub-
units (Fig. 10A–C). GABA- expressing
cells were also detectable in the postnatal
striatum and adjacent SVZ regions (Fig.
10E,F). Finally, we wanted to assess cell
proliferation, as described previously
(Yuan et al., 1998), in organotypic slice
(P1, 400 m thick) cultures to gain more
insights from a cytoarchitecturally intact
postnatal striatum (Fig. 10G), closer to the
in vivo situation. To restrict our analysis to
the postnatal striatum, SVZ regions (as de-
fined in Fig. 10A1) were microdissected
out and assessed similarly but separately.
BrdU incorporation was performed dur-
ing the first 24 hr of culture, i.e., between
4 and22 hr after dissection. Slices next
were mechanically dissociated and plated
onto poly-ornithine-coated coverslips to
attach for 1 hr before fixation and immu-
nostaining (Fig. 10H). We ascertained the
viability of our slice culture system by run-
ning LIVE/DEAD cytotoxicity assays just
before fixation after each experiment,
yielding to values of 88.6 0.6 living cells
and 11.4  0.6 dead cells (percentage of
total cells; mean  SEM; n  3 indepen-
dent experiments).
In EGF-free conditions, consistent with
our data from cultured cells, we observed
in situ that the GABAAR agonist muscimol
(100M) inhibited proliferation of striatal
PSA-NCAM cells both at the Tuj1 stage (Fig. 10 I) and in
neuron-committed Tuj1 cells (Fig. 10 J). Likewise, the addition
of SR95531 (10 M) totally abolished muscimol-induced inhibi-
tion of proliferation in striatal PSA-NCAM cells at both the
Tuj1 (Fig. 10 I) and Tuj1 stages (Fig. 10 J). Furthermore, in the
absence of exogenously applied GABAAR agonists, SR95531
stimulated the proliferation of Tuj1 (Fig. 10 I) and Tuj1 (Fig.
10 J) cells within the PSA-NCAM population, just as was shown
in spheres.
We also confirmed with this ex vivo paradigm that EGF (20
ng/ml) stimulated proliferation of striatal PSA-NCAM cells
Figure 5. GABAAR activation inhibits the proliferation of PSA-NAM
 cells at both Tuj1 and Tuj1 stages. Cells were
incubated simultaneously with drugs and BrdU (20M) for 18 hr in EGF-free medium. The anti-mitotic agent cytosine arabinoside
(AraC, 10 M) was used as an internal control condition. (A, D, G). GABAAR agonists (100 M GABA and 100 M muscimol)
inhibited the incorporation of BrdU (n 6; ANOVA-1 followed by a Dunnett’s post-test; *p	 0.05, **p	 0.01, ***p	 0.0001)
in total PSA-NCAM cells ( A), in Tuj1/PSA-NCAM cells ( D), and in Tuj1/PSA-NCAM cells ( G). The effect of muscimol was
totally abolished by SR-95531 (100M). Baclofen (100M), a GABABR agonist, had no effect on BrdU incorporation. (A, D, G).
Muscimol (100M) significantly inhibited (n 4; Student’s t test; *p	 0.05) the mitogenic effect of EGF (20 ng/ml) (n 4,
Student’s t test; **p	 0.01, ***p	 0.0001) in total PSA-NCAM cells ( B) and in Tuj1/PSA-NCAM cells ( E), but not in
Tuj1/PSA-NCAM cells ( H ). C, F, I, Confocal images of double-immunostaining for PSA-NCAM (red) and BrdU (green) ( C ),
triple-immunostaining for PSA-NCAM (red), Tuj1 (blue), and BrdU (green) (F, I ), respectively, showing that both Tuj1/PSA-
NCAM and Tuj1/PSA-NCAM cells are proliferative. Because a vast majority of cells constituting 3-DIV spheres expressed
PSA-NCAM, we found similar results on the whole-cell population, and these results were confirmed in [ 3H]thymidine incorpo-
ration assay (data not shown, but see Fig. 8). Scale bars: C, F, I, 10m.
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at both the Tuj1 (Fig. 10 I) and Tuj1
stages (Fig. 10 J). In contrast to data from
cultured cells, muscimol (100 M) inhib-
ited EGF-induced increase of proliferation
in striatal PSA-NCAM cells not only at
the Tuj1 (Fig. 10 I) but also at the Tuj1
stage, although without statistical signifi-
cance. Finally, in the presence of EGF,
SR95531 (10 M) did not increase prolif-
eration of PSA-NCAM cells at either the
Tuj1 (Fig. 10 I) or Tuj1 stage (Fig. 10 J),
thus suggesting that EGF may also interact
with GABA synthesis in situ in such orga-
notypic striatal slices. Altogether, such
findings emphasize that an autocrine/
paracrine GABAAR activation may be an
essential mechanism for cell cycle control
in PSA-NCAM cells from the postnatal
striatum in vivo.
Interestingly, using this organotypic
slice culture technique, we observed that
the regulation of proliferative kinetics of
Tuj1/PSA-NCAM and Tuj1/PSA-
NCAM cells in response to EGF applica-
tion and GABAAR activation appears to be
qualitatively identical in the SVZ (micro-
dissected as defined in Fig. 10A1) (Fig.
10K,L) as compared with that of the stria-
tum area (microdissected as defined in Fig.
10A1) (Fig. 10 I, J).
Discussion
The generation of cell diversity from
mammalian NSCs is likely to be controlled
by the interaction between both extrinsic
and intrinsic cues. In addition to growth
factors, hormones, integrins, and extracel-
lular matrix components, neurotransmit-
ters are present in the developing brain
well before the onset of synaptic activity
and have been shown to be part of the ex-
trinsic control of CNS neurogenesis in-
volving progenitor cell proliferation, mi-
gration, and differentiation as well as cell
death (for review see Lauder, 1993; Cam-
eron et al., 1998; Herlenius and Lager-
crantz, 2001; Nguyen et al., 2001). Recent
studies reported that functional neuro-
transmitter receptors are expressed by a
wide variety of neuronal progenitors dur-
ing embryonic development, thus pointing to a possible role in
the transduction of important developmental cues (LoTurco et
al., 1995; Flint et al., 1998; Haydar et al., 2000; Maric et al., 2000).
In the present work, we show that (1) proliferative PSA-NCAM
neuronal precursors from early postnatal rat striata synthesize
and release GABA and express functional GABAAR in vitro and in
situ, (2) an EGF-dependent GABA-mediated autocrine/para-
crine loop regulates neuronal precursor cell division in the post-
natal striatum, and, (3) the levels of GABA synthesized by PSA-
NCAM cells in vitro were found to be in the same range of
concentration as that of GABAergic brain areas in vivo (Miranda-
Contreras et al., 1999). This work emphasizes that GABA may
serve as a physiological signal that could regulate proliferation of
neuronal progenitors and likely neurogenesis in the postnatal
striatum.
Functional GABAA receptors are expressed in postnatal
PSA-NCAM cells
GABA, the principal inhibitory neurotransmitter of the adult
CNS, may act as a trophic factor during CNS development long
before the onset of inhibitory synaptogenesis (Barker et al., 1998).
We wanted to determine whether functional GABAARs were ex-
pressed in neurogenic PSA-NCAM progenitors isolated from
rat striatum at the early postnatal period, when spontaneous and
growth factor-stimulated proliferation is established to persist at
Figure 6. EGF-dependent production of endogenous GABA intrinsically inhibits the proliferation of PSA-NCAM precursor
cells. A, RT-PCR amplification of both GAD 65 and GAD 67 transcripts from 3-DIV PSA-NCAM spheres and from control adult rat
brain using specific sets of primers. RT-PCR analysis yielded bands with the appropriate amplicon size for GAD 65 (698 bp) and for
the full-length functional GAD 67 (252 bp). Left margin indicates migration of standard DNA markers with size indicated in base
pairs. B, C, Three-DIV-old dissociated PSA-NCAM spheres labeled for GAD 65 (B, green) or GAD 67 (C, green) and counterstained
by Etd1 (red). D, Dissociated 3-DIV progenitors immunostained for GABA (green) and counterstained with Etd1 (red). Scale bars:
B–D, 10 m. E, F, Histograms representing the differences of BrdU incorporation index (BrdU cells/total cells, %) between
treated and untreated conditions, respectively, in total PSA-NCAM ( E) and Tuj1/PSA-NCAM cells ( F ). Antagonists and
positive allosteric modulators of GABAAR were applied on 3-DIV-old synchronized cells for 18 hr of BrdU incorporation assay.
GABAAR antagonists (10 M SR-95531, 5 M picrotoxin, and 100 M bicuculline) significantly increased the percentage of
PSA-NCAM/BrdU cells (n 3; ANOVA-1 followed by a Dunnett’s post-test, ns; *p	 0.05) ( E ) and Tuj1/PSA-NCAM/
BrdU cells (n  3; ANOVA-1 followed by a Dunnett’s post-test; *p 	 0.05, **p 	 0.01) ( F ). Conversely, GABAAR-positive
allosteric modulators decreased the percentage of PSA-NCAM/BrdU cells ( E) and Tuj1/PSA-NCAM/BrdU cells ( F ) as
compared with control. Saclofen (10M), a GABABR antagonist, had no effect (E, F ). G, H, In the presence of EGF (20 ng/ml) (n
4; Student’s t test; ***p	 0.0001), SR-95531 (10M) (n 4; Student’s t test; **p	 0.01, ***p	 0.0001) had no effect on
proliferation of total PSA-NCAM cells ( G) and of Tuj1/PSA-NCAM cells ( H ). I, Histogram showing the concentration of GABA
measured by HPLC in synchronized 3-DIV-old PSA-NCAM spheres treated or not with EGF for 18 hr. EGF-treated spheres
contained a lower amount of GABA than that of untreated cultures (n 3; Student’s t test; *p	 0.05).
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a significant rate (Reynolds and Weiss, 1992; Craig et al., 1996;
Pencea et al., 2001). Because immature proliferative cells are
characterized by lower buoyancy or higher specific buoyant den-
sities (Maric et al., 1997), we used these isopycnic properties to
develop a selection procedure that allowed us to obtain highly
pure PSA-NCAM striatal cell suspensions that were enriched in
proliferative progenitors.
After 3 d of growth in uncoated conditions, PSA-NCAM
cells generated spheres and were shown to express multiple
GABAAR subunit genes (i.e.,2,4,5,1,3, and 1–3) that are known
to be necessary for forming heteromeric functional receptors
(Levitan et al., 1988; Malherbe et al., 1990; Sigel et al., 1990;
Verdoorn et al., 1990). It is acknowledged that at least 4, 1, and
1, which are detected in rodent progenitors from the neocortical
proliferative zone (Ma and Barker, 1995, 1998; Ma et al., 1998),
may compose GABAARs that have an extrasynaptic function in
neural development. The absence of transcript coding for 1, 3,
2, and  subunits in PSA-NCAM
 spheres was expected because
these GABAAR subunits have been reported mostly in differenti-
ating postmitotic neurons (Maric et al., 1997; Serafini et al., 1998;
Stewart et al., 2002). At the protein level, we observed that PSA-
NCAM cells were intensely (70%) immunoreactive for -,
-, and -GABAAR subunits. Our electrophysiological record-
ings confirmed that GABA and muscimol elicited chloride cur-
rents in PSA-NCAM cells. Finally, we provided evidence that
GABA-evoked currents in PSA-NCAM progenitors displayed a
typical pharmacological profile with reversible inhibition by es-
tablished antagonists and potentiation by positive allosteric
modulators of GABAAR. Altogether, our findings indicate that
fully functional GABAARs are expressed by striatal PSA-NCAM

precursor cells from early postnatal brain.
Autocrine/paracrine activation of GABAA receptor blocks cell
cycle progression in PSA-NCAM neuronal progenitor cells
from postnatal striatum
In the present study, we provided evidence in vitro and in situ that
EGF increased the proliferation of postnatal striatal PSA-
NCAM progenitors at both the Tuj1 and neuron-committed
Tuj1 stages. Furthermore, we showed that the activation of
GABAAR had no effect on apoptotic events but inhibited the
proliferation of postnatal striatal PSA-NCAM progenitors and
of their Tuj1 neuroblastic progeny in vitro and in situ, either in
the presence or in the absence of EGF mitogenic stimulation.
Conversely, GABAAR activation had no effect on the prolifera-
tion of O4 oligodendroglial cells and GFAP astrocytes that
were only sparsely present in cultured PSA-NCAM spheres. In
our culture conditions, a large majority of striatal PSA-NCAM
cells were Tuj1 and underwent preferentially a neuronal differ-
entiation as depicted by the expression of antigenic features of
mature neurons. These results suggest that, in the postnatal stri-
atum, GABAAR-mediated signaling may be involved in the regu-
lation of cell cycle progression specifically in PSA-NCAM pre-
cursor cells that are directed toward a neuronal fate.
GABA-, GAD 65-, and GAD 67-expressing cells have been
detected in embryonic and early postnatal rat striatum (Lauder et
al., 1986; Greif et al., 1992), and extrasynaptically released GABA
was found to be necessary for the establishment and patterning of
functional neuronal networks by promoting the survival and po-
Figure 7. GABAAR modulators do not interfere with PSA-NCAM
 cell survival. A, Histogram
showing a TUNEL bioassay that demonstrated the absence of effect of GABAAR modulators on
apoptotic events in PSA-NCAM cell cultures (3-DIV, 18 hr of treatment in the different condi-
tions. Roscovitine (40 M) was used as a positive control (n  3; ANOVA-1 followed by a
Dunnett’s post-test; **p	 0.01). B, Confocal images displaying representative fields compar-
ing the percentage of TUNEL cells (green) in control (top row) versus roscovitine-treated
(bottom row) conditions.
Figure 8. GABAAR activation inhibits proliferation of PSA-NCAM
 progenitors by blocking
MAPK signaling pathways. Histogram shows that the increase of [ 3H]-thymidine incorporation
induced by the GABAAR antagonist SR95531 (10M) and by EGF (20 ng/ml) was significantly
blocked by U0126 (10M), a specific inhibitor of the mitogen-activated protein kinase kinases
MEK1 and MEK2 (n 5; Student’s t test; *p	 0.05, **p	 0.01).
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sitioning of newly generated neurons in the striatum (Ikeda et al.,
1997; Luk and Sadikot, 2001). With respect to hypotheses about
the potential source of GABA that could activate GABAAR in
PSA-NCAM cells in vivo, it is noteworthy that these cells ap-
peared to produce GABA and express consistently GABA-
synthesizing enzymes in vitro. In the absence of extrinsic addition
of GABA or GABAAR agonist, we also showed that the prolifera-
tion of both PSA-NCAM and Tuj1 neuronal precursors was
increased by GABAAR antagonists and decreased by positive al-
losteric modulators of GABAAR. Without extrinsic addition of
GABA but in the presence of the EGF mitogenic effect, we ob-
served that the application of GABAAR antagonists did not fur-
ther stimulate cell cycle progression in PSA-NCAM and Tuj1
neuronal precursors from early postnatal striatum. However, this
discrepancy might be attributable to the fact that EGF decreased
endogenous GABA synthesis in PSA-NCAM spheres. In con-
clusion, these findings demonstrate convincingly that cultured
postnatal PSA-NCAM cells from striatum not only express
GABAARs that regulate their cell cycle but also produce and re-
lease GABA.
Furthermore, in organotypic slice preparations from early
postnatal striatum, we were able to detect GABA and GABAAR
subunits in PSA-NCAM cells, and we provided evidence that an
endogenous GABA production also inhibited proliferation of
PSA-NCAM cells in situ, both at the Tuj1 stage and in
neuron-committed Tuj1 precursor cells. These data suggest
that this autocrine/paracrine mode of regulation of cell cycle pro-
gression through GABAAR activation in postnatal PSA-NCAM

neuronal precursors may likely exist in vivo and could regulate
postnatal striatal neurogenesis. By using a similar experimental
approach, we confirmed that the same mechanism appears to
occur in the SVZ area, as shown previously by other work sug-
gesting that endogenous GABAAR activation does exist in the
proliferative ventricular zone (VZ) and SVZ during late embry-
onic stages of murine cortical development (LoTurco et al., 1995;
Haydar et al., 2000). Studies in organotypic slices have already
demonstrated that GABAAR agonists may have contrasting ef-
fects on neuronal progenitors; i.e., they were found to be mito-
genic in the embryonic VZ and anti-proliferative in the SVZ, but
these works failed to ascertain whether it could be caused by an
indirect receptor activation on other cells that in turn would
regulate proliferation in VZ and SVZ cells (Haydar et al., 2000).
We show here that a direct autocrine/paracrine GABA-mediated
feedback can regulate proliferation of PSA-NCAM cells both in
the striatum and SVZ in situ.
The finding in vitro and in situ that EGF stimulates the prolif-
eration of early postnatal PSA-NCAM cells and particularly
Tuj1/PSA-NCAM neuronal progenitors must be put in per-
spective with the effect of EGF on GABA synthesis in these cells. It
has not yet been determined to what extent the EGF mitogenic
4
over, the [Ca]i increase induced by muscimol (100M) was significantly reduced by nifedipine
(10 M; n  20) (ANOVA-1 followed by a Dunnett’s post-test; **p 	 0.01). Examples of
responsive cells are represented on the right in the image series. Cells that were both depolar-
ization responsive and muscimol responsive are indicated by open arrows, and cells that were
depolarization responsive but muscimol nonresponsive are indicated by white arrows. C, Histo-
grams showing that the inhibition of proliferation induced by muscimol (100M) in Tuj1/
PSA-NCAM cells was completely blocked by nifedipine (10M). When applied alone, nifed-
ipine significantly increased the proliferation of Tuj1/PSA-NCAM cells (n4 –5; Student’s
t test; ***p	 0.0001). D, In contrast, nifedipine (10M) did not block the inhibition of prolif-
eration mediated by muscimol (100M) in Tuj1/PSA-NCAM cells and did not increase the
proliferation of these cells when applied alone (n 4 –5; Student’s t test; *p	 0.05).
Figure 9. GABAAR activation inhibits the proliferation of Tuj1
/PSA-NCAM progenitors
by inducing a rise of intracellular calcium concentration. A, Time course (Ft /F0 ) of intracellular
calcium concentration [Ca]i assessed in cultured (3 DIV) fluo-3 AM-loaded PSA-NCAM
 cells.
We displayed fluorescence data recordings and fluo-3 AM on the basis of confocal images from
two different cells (i.e., depolarization and muscimol responsive, open circles in the dot plot;
depolarization responsive and muscimol nonresponsive, black circles in the dot plot) during
successive treatments with solutions containing a high extracellular K concentration (50 mM),
muscimol (100M), or muscimol (100M) nifedipine (10M). The [Ca]i increase mediated
by muscimol (100 M) was abolished by the L-type voltage-gated calcium channel-blocker
nifedipine (10 M) (open circle-containing curve). B, Histogram representing the increase of
[Ca]i (Ft /F0 , %) triggered by a high extracellular K
 concentration (50 mM; n  28) and
muscimol (100M; n 20) (ANOVA-1 followed by a Dunnett’s post-test; **p	 0.01). More-
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effect on PSA-NCAM cells may be caused in part by an EGF-
mediated decrease of endogenous GABA production by PSA-
NCAM cells. Previous works have shown in vivo that intracere-
broventricular administration of EGF induced newly formed
cells in the adult mouse brain (Craig et al., 1996; Kuhn et al.,
1997). However, although EGF promoted an increase of newborn
cells in the adult SVZ and striatum, most of these cells were glial
cells (Kuhn et al., 1997). There is an apparent discrepancy be-
tween our data showing that EGF is a potent mitogen for PSA-
NCAM neuronal precursors from the early postnatal striatum
and the demonstration that EGF signaling has no effect on adult
striatal neurogenesis and is preferentially a glial inducer in the
adult SVZ and striatum (Craig et al., 1996; Kuhn et al., 1997),
which contain PSA-NCAM cells (Butler et al., 1997; Doetsch et
al., 1997). We propose the following: (1) there may be a develop-
mental regulation of the phenotypic potential of adult versus
neonatal EGF-responsive PSA-NCAM precursors from a given
germinative postnatal region of the CNS, and (2) the effect of
EGF on GABA synthesis, or the expression and function of
GABAAR, might differ in adult PSA-NCAM
 precursors. To ad-
dress this issue, adult PSA-NCAM cells obtained from the SVZ
and tightly adjacent areas will need to be investigated further with
the experimental paradigm used in the present study.
MAPK signaling pathways and intracellular calcium are
involved in GABAA receptor-mediated inhibition of
proliferation in PSA-NCAM neuronal progenitor cells from
postnatal striatum
We also wanted to determine whether the proliferation of post-
natal PSA-NCAM precursors could be dependent on the
MAPK pathway (Grewal et al., 1999), which is activated in the
EGF receptor-signal transduction cascade (Grant et al., 2002) and
appears to play a crucial ubiquitous role in the regulation of cell
cycle progression in many cell types (Wilkinson and Millar, 2000;
Li et al., 2001). Hence, to investigate the function of MAPK in the
signal transduction of EGF- and GABAAR-mediated regulation
of cell cycle progression in PSA-NCAM cells, we used U0126, a
specific inhibitor of the MAPK kinases MEK1 and MEK2. As in
other cell types (Grant et al., 2002), our results confirmed that
EGF-dependent stimulation of PSA-NCAM cell proliferation is
Figure 10. GABAAR expression and activation in brain slices: the activation of GABAAR inhib-
its the proliferation of PSA-NCAM cells in the postnatal striatum and adjacent SVZ. A1–3,
Confocal single plane images of immunohistochemical stainings (30-m-thick tissue sections)
showing a field containing the striatum separated from the subventricular zone (SVZ) by a white
dotted line and bordered by the lateral ventricle (LV). PSA-NCAM staining appears in green (A1),
GABAAR  appears in red (A2), and merge of A1 and A2 appears in A3. B1– 4, High-
magnification views of the field delimited by the boxed area B of A1, which is a representative
field of the striatum, with nuclei in blue (B1), PSA-NCAM in green (B2), GABAAR in red (B3),
and merge of B1, B2, and B3 in B4. Insets display two PSA-NCAM cells (high magnification)
that are immunoreactive (arrowhead) or not immunoreactive (arrow), respectively, for GABAAR
. C1– 4, High-magnification views of the field delimited by the boxed area C of A1, which is a
representative field of the SVZ, with nuclei in blue (C1), PSA-NCAM in green (C2), GABAAR in
red (C3), and merge of C1, C2, and C3 in C4. Insets show two PSA-NCAM cells (high magnifi-
cation) immunoreactive (arrowhead) or not immunoreactive (arrow), respectively, for GABAAR
. E, F, Confocal images showing immunostaining of a striatal area ( E ) and an SVZ area ( F) with
nuclei in red and GABA staining in green. Insets display a GABA cell (arrow in full image) at
higher magnification. G, Proliferation assay in acutely dissected organotypic tissue slices from
postnatal striatum (Z-series confocal image) treated with EGF. We show BrdU (green) immu-
4
nostaining in a PSA-NCAM (red)-expressing cell of a striatal slice after 18 hr of BrdU incorpora-
tion. Inset displays one cell (corresponding to the arrow in the full image) viewed as stacked
Z-dimension images, comprising 0.5m optical sections taken 3m apart. The Z-dimension
reconstruction was also observed orthogonally in both X–Z and Y–Z planes that are shown
under and to the right of each Z-dimension composite, respectively. H, Confocal image of
acutely isolated cells derived from mechanical dissociation of the striatal part of 400-m-thick
tissue slices at the end of the BrdU incorporation assay. These cells were immunostained for
PSA-NCAM (red) and BrdU (green). Scale bars: C1– 4, 30m; B1– 4, E–H, 40m; A1–3, 500
m. I–L, Histograms showing BrdU labeling indexes in Tuj1/PSA-NCAM (I, K ) and Tuj1/
PSA-NCAM (J, L) cells from the striatum (I, J ) and the SVZ (K, L), as defined in A1. Striatal and
SVZ areas were separated by microdissection of organotypic slices, placed in the same well, and
then incubated with drugs and BrdU (20M) for 18 hr. In EGF-free medium, 100M muscimol
inhibited the incorporation of BrdU in Tuj1/PSA-NCAMand Tuj1/PSA-NCAM cells from
the striatum (I, J ) and from the SVZ (K, L). These effects were totally abolished by SR-95531 (10
M). Moreover, when applied alone, SR-95531 significantly increased the incorporation of BrdU
in Tuj1/PSA-NCAM cells and in Tuj1/PSA-NCAM cells from the striatum (I, J ) and from
the SVZ (K, L) (n 2– 4; ANOVA-1 followed by a Dunnett’s post-test; *p	 0.05, **p	 0.01).
EGF (20 ng/ml) significantly increased the incorporation of BrdU in Tuj1/PSA-NCAM and
Tuj1/PSA-NCAM cells from the striatum (I, J ) and from the SVZ (K, L). In EGF-containing
medium, muscimol exerted similar but less significant effects than in EGF-free conditions,
and SR95531 had no effect when applied alone (n  2–5; Student’s t test; *p 	 0.05,
**p	 0.01).
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mediated by the activation of the MAPK cascade because U0126
totally abolished the increase of proliferation induced by EGF.
Furthermore, U0126 had no effect on the low level of PSA-
NCAM cell proliferation in basal conditions in which endoge-
nous GABA was shown to inhibit cell cycle progression. Con-
versely, U0126 inhibited the higher level of proliferation of PSA-
NCAM cells observed in the presence of pharmacological
blockers that antagonized GABAAR activation by endogenous
GABA and thereby repressed the potential intracellular pathways
of GABAAR-mediated signaling. Thus, these data consistently
suggest that the autocrine/paracrine activation of GABAAR inter-
acts with cell cycle progression in PSA-NCAM cells, leading
directly or indirectly to a tonic inhibition of MAPK activity.
Despite its role as a major inhibitory neurotransmitter in the
adult brain, GABA is known to exert excitatory depolarizing in-
puts during the period of embryonic neurogenesis and until the
first postnatal week (Owens and Kriegstein, 2002). Membrane
depolarization evoked by GABA in immature neural cells results
from a high intracellular chloride concentration maintained by
specific regulations of chloride transport mechanisms (Kakazu et
al., 1999; Rivera et al., 1999; Bettendorff et al., 2002).
Depolarization-induced Ca 2 entry through VGCCs (LoTurco
et al., 1995) is known to be a major mechanism by which GABA-
mediated changes in membrane potential used to regulate gene
expression (Ganguly et al., 2001). We showed here that GABAAR
activation induced an increase of [Ca 2]i in a subset of postnatal
PSA-NCAM neuronal precursor cells. However, as a matter of
fact, because only 28% of striatal PSA-NCAM cells expressed
VGCCs, only 20% of the total cells responded to GABAAR ago-
nists with an increase of [Ca 2]i, all by a mechanism involving
VGCC opening. We also demonstrated that VGCC blockade by
nifedipine reversed GABAAR-mediated inhibition of proliferation
in Tuj1/PSA-NCAM striatal neuronal precursors but had no ef-
fect on uncommitted Tuj1/PSA-NCAM cells. To explain this
difference, one could assume that in comparison with Tuj1/PSA-
NCAM striatal precursors, more immature Tuj1/PSA-NCAM
cells either have specific calcium-insensitive cell cycle signaling path-
ways or may not elicit a [Ca2]i rise in response to GABAAR agonists
because of lower levels of VGCC expression or specific regulations of
chloride transport mechanisms or express nifedipine-insensitive
VGCC. It remains to be elucidated to what extent and by which
mechanism GABAAR-induced depolarization and elevation of
[Ca2]i might account for the tonic inhibition of the MAPK path-
way that actively decreases proliferation in PSA-NCAM neuronal
precursors.
In conclusion, altogether our findings show that GABA acting
via GABAAR activation is a growth regulatory signal that controls
proliferation of PSA-NCAM neuronal progenitors isolated
from early postnatal striatum. Because cell cycle arrest and neu-
ronal differentiation are tightly linked biological events (Perez-
Juste and Aranda, 1999), GABAAR activation could influence not
only the maintenance but also the fate specification and the rate
of neuronal differentiation of PSA-NCAM precursor cells in
the postnatal brain.
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